Close

ContraVir Pharma (CTRV) Prices Common Stock, Warrants Offering for Proceeds of ~$7M

March 30, 2016 9:13 AM EDT Send to a Friend
ContraVir Pharmaceuticals, Inc. (Nasdaq: CTRV) ("ContraVir" or the "Company"), a biopharmaceutical company focused on the development and commercialization of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login